Trials / Terminated
TerminatedNCT04716413
Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment
Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment Who Are Undergoing Ambulatory Surgery- a Case Series
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Montefiore Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
In this case series study, the investigators are testing the hypothesis that sublingual sufentanil (Dsuvia) will improve postoperative pain management in the Post Anesthesia Care Unit (PACU) in ambulatory surgery patients taking Suboxone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dsuvia | Subject will receive up to 2 doses of Dsuvia. The first dose will be intra-op and the second dose will be post-op (if needed) |
Timeline
- Start date
- 2021-09-27
- Primary completion
- 2022-11-17
- Completion
- 2022-11-18
- First posted
- 2021-01-20
- Last updated
- 2023-07-19
- Results posted
- 2023-07-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04716413. Inclusion in this directory is not an endorsement.